Weathering of Antibacterial Melt-Spun Polyfilaments Modified by Pine Rosin.

For many antibacterial polymer fibres, especially for those with natural functional additives, the antibacterial response might not last over time. Moreover, the mechanical performance of polymeric fibres degrades significantly during the intended operation, such as usage in textile and industrial filter applications. The degradation process and overall ageing can lead to emitted volatile organic compounds (VOCs). This work focused on the usage of pine rosin as natural antibacterial chemical and analysed the weathering of melt-spun polyethylene (PE) and poly lactic acid (PLA) polyfilaments. A selected copolymer surfactant, as an additional chemical, was studied to better integrate rosin with the molecular structure of the plastics. The results reveal that a high 20 w-% of rosin content can be obtained by surfactant addition in non-oriented PE and PLA melt-spun polyfilaments. According to the VOC analysis, interestingly, the total emissions from the melt-spun PE and PLA fibres were lower for rosin-modified (10 w-%) fibres and when analysed below 60 ℃. The PE fibres of the polyfilaments were found to be clearly more durable in terms of the entire weathering study, i.e., five weeks of ultraviolet radiation, thermal ageing and standard washing. The antibacterial response against Gram-positive Staphylococcus aureus by the rosin-containing fibres was determined to be at the same level (decrease of 3-5 logs cfu/mL) as when using 1.0 w-% of commercial silver-containing antimicrobial. For the PE polyfilaments with rosin (10 w-%), full killing response (decrease of 3-5 logs cfu/mL) remained after four weeks of accelerated ageing at 60 ℃.

Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.

OBJECTIVES: The aim of this study was to demonstrate the feasibility of combining the novel heart valve replacement technologies of: 1) tissue engineering; and 2) minimally-invasive implantation based on autologous cells and composite self-expandable biodegradable biomaterials. BACKGROUND: Minimally-invasive valve replacement procedures are rapidly evolving as alternative treatment option for patients with valvular heart disease. However, currently used valve substitutes are bioprosthetic and as such have limited durability. To overcome this limitation, tissue engineering technologies provide living autologous valve replacements with regeneration and growth potential. METHODS: Trileaflet heart valves fabricated from biodegradable synthetic scaffolds, integrated in self-expanding stents and seeded with autologous vascular or stem cells (bone marrow and peripheral blood), were generated in vitro using dynamic bioreactors. Subsequently, the tissue engineered heart valves (TEHV) were minimally-invasively implanted as pulmonary valve replacements in sheep. In vivo functionality was assessed by echocardiography and angiography up to 8 weeks. The tissue composition of explanted TEHV and corresponding control valves was analyzed. RESULTS: The transapical implantations were successful in all animals. The TEHV demonstrated in vivo functionality with mobile but thickened leaflets. Histology revealed layered neotissues with endothelialized surfaces. Quantitative extracellular matrix analysis at 8 weeks showed higher values for deoxyribonucleic acid, collagen, and glycosaminoglycans compared to native valves. Mechanical profiles demonstrated sufficient tissue strength, but less pliability independent of the cell source. CONCLUSIONS: This study demonstrates the principal feasibility of merging tissue engineering and minimally-invasive valve replacement technologies. Using adult stem cells is successful, enabling minimally-invasive cell harvest. Thus, this new technology may enable a valid alternative to current bioprosthetic devices.